Shifting Focus: Key Factors for Longevity Investments

Over the last few days I’ve written about why AI is getting cheap — and why longevity breaks most AI-first companies." "" "Here’s how this has fundamentally changed how I look at longevity businesses and investments." "" "I no longer optimize for:" "How impressive the tech sounds" "How fast the MVP was built" "How smart the model is" "" "I optimize for:" "Can this work with real clients?" "Can it be executed daily, under pressure?" "Can clinicians actually use it?" "Can people stick to it long enough to matter?" "Can it deliver outcomes, not just insights?" "" "In longevity, the hardest part isn’t intelligence." "" "It’s consistency over time." "" "That’s why the real advantage doesn’t sit in code anymore." "" "It sits in:" "Operational discipline" "Distribution" "Trust" "And the ability to execute in the real world" "" "That’s what I’m focused on building." "And that’s what I now look for as an investor." "" "Where do you think the real moat in longevity will be built over the next few years?" "" "#Longevity #HealthTech #AI #VentureCapital #FounderOperator